2019 Q1 Form 10-Q Financial Statement

#000156459020023542 Filed on May 08, 2020

View on sec.gov

Income Statement

Concept 2019 Q1
Revenue $1.429B
YoY Change 0.24%
Cost Of Revenue $1.094B
YoY Change 0.63%
Gross Profit $335.0M
YoY Change -1.0%
Gross Profit Margin 23.44%
Selling, General & Admin $320.4M
YoY Change -6.2%
% of Gross Profit 95.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $17.45M
YoY Change 1.91%
% of Gross Profit 5.21%
Operating Expenses $389.6M
YoY Change -1.56%
Operating Profit -$54.63M
YoY Change -4.82%
Interest Expense $40.45M
YoY Change 2.23%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$95.08M
YoY Change -1.94%
Income Tax -$27.00M
% Of Pretax Income
Net Earnings -$68.09M
YoY Change 2.15%
Net Earnings / Revenue -4.76%
Basic Earnings Per Share -$1.08
Diluted Earnings Per Share -$1.08
COMMON SHARES
Basic Shares Outstanding 68.45M
Diluted Shares Outstanding 68.45M

Balance Sheet

Concept 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $600.0K
YoY Change -96.25%
Cash & Equivalents $645.0K
Short-Term Investments
Other Short-Term Assets $332.1M
YoY Change 38.2%
Inventory $1.031B
Prepaid Expenses
Receivables $869.8M
Other Receivables $0.00
Total Short-Term Assets $2.234B
YoY Change 6.64%
LONG-TERM ASSETS
Property, Plant & Equipment $271.0M
YoY Change -7.89%
Goodwill $2.490B
YoY Change 4.56%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.200M
YoY Change -20.58%
Total Long-Term Assets $3.993B
YoY Change -2.33%
TOTAL ASSETS
Total Short-Term Assets $2.234B
Total Long-Term Assets $3.993B
Total Assets $6.226B
YoY Change 0.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $510.4M
YoY Change -14.01%
Accrued Expenses $453.9M
YoY Change 30.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $20.00M
YoY Change 2.04%
Total Short-Term Liabilities $984.3M
YoY Change 2.4%
LONG-TERM LIABILITIES
Long-Term Debt $2.920B
YoY Change -0.58%
Other Long-Term Liabilities $5.702M
YoY Change -46.29%
Total Long-Term Liabilities $5.702M
YoY Change -46.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $984.3M
Total Long-Term Liabilities $5.702M
Total Liabilities $4.020B
YoY Change 0.51%
SHAREHOLDERS EQUITY
Retained Earnings $752.9M
YoY Change 1.31%
Common Stock $1.074B
YoY Change 1.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.807B
YoY Change
Total Liabilities & Shareholders Equity $6.226B
YoY Change 0.71%

Cashflow Statement

Concept 2019 Q1
OPERATING ACTIVITIES
Net Income -$68.09M
YoY Change 2.15%
Depreciation, Depletion And Amortization $17.45M
YoY Change 1.91%
Cash From Operating Activities $94.80M
YoY Change 17.76%
INVESTING ACTIVITIES
Capital Expenditures -$14.60M
YoY Change -16.09%
Acquisitions
YoY Change
Other Investing Activities $1.100M
YoY Change -100.04%
Cash From Investing Activities -$13.60M
YoY Change -99.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -98.70M
YoY Change -107.5%
NET CHANGE
Cash From Operating Activities 94.80M
Cash From Investing Activities -13.60M
Cash From Financing Activities -98.70M
Net Change In Cash -17.50M
YoY Change -98.7%
FREE CASH FLOW
Cash From Operating Activities $94.80M
Capital Expenditures -$14.60M
Free Cash Flow $109.4M
YoY Change 11.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 becn Cares Act Of2020 Carryback Period Of Net Operating Losses
CARESActOf2020CarrybackPeriodOfNetOperatingLosses
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2020Q1 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
5600000
us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
5600000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-161000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4661000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22342000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-122640000
CY2020Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
6000000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
1884305000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2058000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8264000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2390000
us-gaap Net Income Loss
NetIncomeLoss
-68979000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
12000000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1807142000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1862353000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1387000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9817000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-18525000
us-gaap Net Income Loss
NetIncomeLoss
-146050000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
12000000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1694208000
us-gaap Profit Loss
ProfitLoss
-68979000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
138832000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-129282000
us-gaap Share Based Compensation
ShareBasedCompensation
8264000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-242144000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26320000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
163973000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1428000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-188865000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1880684000
becn Interest Expenses And Other Financing Costs
InterestExpensesAndOtherFinancingCosts
6051000
becn Amortization Of Beneficial Lease
AmortizationOfBeneficialLease
1145000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1172000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
3086000
becn Business Acquisition Purchase Price And Tax Position Refund Amount
BusinessAcquisitionPurchasePriceAndTaxPositionRefundAmount
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-219740000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
96052000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
85320000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-368154000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-415000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1557615000
becn Payments Under Term Loan
PaymentsUnderTermLoan
4850000
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0
becn Payment Under Senior Notes
PaymentUnderSeniorNotes
0
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
becn Payments Under Equipment Financing Facilities And Finance Leases
PaymentsUnderEquipmentFinancingFacilitiesAndFinanceLeases
2642000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
12000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1559000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3617000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
301519000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
208000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
645000
us-gaap Interest Paid Net
InterestPaidNet
77336000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-11073000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1997-08-22
CY2020Q1 becn Number Of Branches In Which Entity Operates
NumberOfBranchesInWhichEntityOperates
528
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in these consolidated financial statements and accompanying notes. Significant items subject to such estimates include accounts receivable, inventories, purchase price allocations, goodwill and intangibles, and income taxes. Assumptions made in the development of these estimates contemplate the impact of the novel coronavirus (“COVID‑19”) on the economy and our anticipated results; however, actual amounts could differ from these estimates. </p>
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1429037000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1458486000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3150713000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3133598000
us-gaap Net Income Loss
NetIncomeLoss
-68979000
becn Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-80979000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68820155
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.87
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.87
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
4850000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5530536
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0174
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.3318
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2339489
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.61
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12034000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
76329
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
18.95
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
20728
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
36.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2534
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
14.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
407736
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
33.47
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2647634
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
33.12
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2589890
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
33.14
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
342000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1733712
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
33.35
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
334000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.70
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3937000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1094000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
33.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
13362000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
9093000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-940000
CY2019Q1 us-gaap Goodwill
Goodwill
2490326000
CY2018Q3 us-gaap Goodwill
Goodwill
2491779000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-513000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1955000
CY2020Q1 us-gaap Goodwill
Goodwill
2488635000
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1494067000
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
655417000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
838650000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
187400000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
88344000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
147987000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
120540000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
97416000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
78771000
CY2020Q1 becn Cares Act Of2020 Income Tax Benefit On Effective Tax Rate Adjustment
CARESActOf2020IncomeTaxBenefitOnEffectiveTaxRateAdjustment
15900000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
305592000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
838650000
CY2020Q1 us-gaap Senior Notes Current
SeniorNotesCurrent
0
CY2020Q1 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1580083000
CY2020Q1 becn Term Loans And Senior Notes Net
TermLoansAndSeniorNotesNet
2494821000
CY2020Q1 becn Equipment Financing Facilities Borrowings Outstanding
EquipmentFinancingFacilitiesBorrowingsOutstanding
4675000
CY2019Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
6713000
CY2018Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3570000000
CY2018Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
65300000
CY2020Q1 becn Cares Act Of2020 Carryback Net Operating Loss Beginning Date
CARESActOf2020CarrybackNetOperatingLossBeginningDate
2017-12-31
CY2020Q1 becn Cares Act Of2020 Carryback Net Operating Loss Ending Date
CARESActOf2020CarrybackNetOperatingLossEndingDate
2021-01-01
CY2020Q1 becn Cares Act Of2020 Income Tax Expense Benefit
CARESActOf2020IncomeTaxExpenseBenefit
-33300000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2020Q1 becn Cares Act Of2020 Change In Tax Rate Deferred Tax Liability Income Tax Benefit
CARESActOf2020ChangeInTaxRateDeferredTaxLiabilityIncomeTaxBenefit
17400000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2020Q1 becn Cares Act Of2020 Write Off Of Trade Names With Impact Of Rebranding
CARESActOf2020WriteOffOfTradeNamesWithImpactOfRebranding
142600000
CY2020Q1 becn Cares Act Of2020 Impact Of Rebranding Deferred Tax Liability Income Tax Benefit
CARESActOf2020ImpactOfRebrandingDeferredTaxLiabilityIncomeTaxBenefit
36500000

Files In Submission

Name View Source Status
0001564590-20-023542-index-headers.html Edgar Link pending
0001564590-20-023542-index.html Edgar Link pending
0001564590-20-023542.txt Edgar Link pending
0001564590-20-023542-xbrl.zip Edgar Link pending
becn-10q_20200331.htm Edgar Link pending
becn-10q_20200331_htm.xml Edgar Link completed
becn-20200331.xsd Edgar Link pending
becn-20200331_cal.xml Edgar Link unprocessable
becn-20200331_def.xml Edgar Link unprocessable
becn-20200331_lab.xml Edgar Link unprocessable
becn-20200331_pre.xml Edgar Link unprocessable
becn-ex102_174.htm Edgar Link pending
becn-ex103_176.htm Edgar Link pending
becn-ex104_177.htm Edgar Link pending
becn-ex105_175.htm Edgar Link pending
becn-ex106_178.htm Edgar Link pending
becn-ex311_6.htm Edgar Link pending
becn-ex312_10.htm Edgar Link pending
becn-ex321_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending